Table 1.
Correlation between KIF14 expression and clinical classification in OSCCs.
| Clinical classification | Total |
Results of immunostaining no. of patients (%) |
Pvalue | |
|---|---|---|---|---|
| KIF14 negative | KIF14 positive | |||
| Age at surgery (years) | ||||
| <60 | 18 | 9 (50) | 9 (50) | 0.382 |
| ≧60, <70 | 24 | 8 (35) | 16 (65) | |
| ≧70 | 62 | 23 (37) | 39 (63) | |
| Gender | ||||
| Male | 65 | 24 (37) | 41 (63) | 0.438 |
| Female | 39 | 16 (41) | 23 (59) | |
| T-primary tumor | ||||
| T1 | 6 | 4 (67) | 2 (33) | 0.019⁎ |
| T2 | 54 | 25 (46) | 29 (54) | |
| T3 | 20 | 6 (30) | 14 (70) | |
| T4 | 24 | 5 (22) | 19 (78) | |
| N-regional lymph node | ||||
| Negative | 62 | 22 (35) | 40 (65) | 0.121 |
| Positive | 42 | 18 (44) | 24 (56) | |
| Stage | ||||
| I | 5 | 3 (60) | 2 (40) | 0.563 |
| II | 42 | 17 (37) | 25 (63) | |
| III | 19 | 6 (32) | 13 (68) | |
| IV | 38 | 14 (39) | 24 (61) | |
| Vascular invasion | ||||
| Negative | 85 | 36 (43) | 49 (57) | 0.439 |
| Positive | 19 | 4 (21) | 15 (79) | |
| Histopathologic type | ||||
| Well | 64 | 24 (38) | 40 (62) | 0.512 |
| Moderately | 33 | 13 (40) | 20 (60) | |
| Poorly | 7 | 3 (43) | 4 (57) | |
| Tumoral site | ||||
| Gingiva | 30 | 15 (50) | 15 (50) | 0.471 |
| Tongue | 58 | 20 (35) | 38 (65) | |
| Buccal mucosa | 10 | 4 (40) | 6 (60) | |
| Oral floor | 6 | 1 (17) | 5 (83) | |
⁎
P<0.05 was considered significant.